Page last updated: 2024-11-02

piperazine and Parkinson Disease, Secondary

piperazine has been researched along with Parkinson Disease, Secondary in 1 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smetanina, OF1
Yurchenko, AN1
Girich Ivanets, EV1
Trinh, PTH1
Antonov, AS1
Dyshlovoy, SA1
von Amsberg, G1
Kim, NY1
Chingizova, EA1
Pislyagin, EA1
Menchinskaya, ES1
Yurchenko, EA1
Van, TTT1
Afiyatullov, SS1

Other Studies

1 other study available for piperazine and Parkinson Disease, Secondary

ArticleYear
Biologically Active Echinulin-Related Indolediketopiperazines from the Marine Sediment-Derived Fungus
    Molecules (Basel, Switzerland), 2019, Dec-23, Volume: 25, Issue:1

    Topics: Alkaloids; Aspergillus; Chromatography, High Pressure Liquid; Geologic Sediments; Humans; Neurons; N

2019